PATENT CLAIM ANALYSIS

Application Number: 15868420
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["424", "093700"]

Abstract:
Disclosed are compositions of matter, cells, protocols and procedures useful for augmentation of one or more therapeutic activities of fibroblast cellular populations. In one embodiment fibroblasts are pretreated with growth factor-comprising composition(s), wherein the growth factor(s) may be cytokines, peptides, and/or proteins. In another embodiment fibroblasts are cultured with platelet rich plasma and/or derivatives from platelet rich plasma. In another embodiment, fibroblasts are cultured under hypoxic conditions prior to administration to an individual. The disclosure further provides means of assessment of fibroblast activity in vitro, including wound repair assay and cytokine production, for example.

Claim (Index 15):
The method of  claim 1 , wherein the fibroblasts are placental, fetal, neonatal, adult or a combination thereof.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 86.0
- Lexical Diversity: 1.54795
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12076846', '14573153', '13185472', '11671082', '12775753']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7153093433043063
- 35 USC 102 Novelty (BERT): 0.5034467510959894
- Combined Prediction Score: 0.6941230840834747
- Mean Citation Score: 188.554822
- Max Citation Score: 210.72258
- Similarity Product: 131.02463866003632

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test